Division of Infectious Diseases, Hospital Clínico Universitario, Zaragoza, Spain.
Instituto de Investigación Sanitaria Aragon, Zaragoza, Spain.
J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):95-101. doi: 10.18176/jiaci.0859. Epub 2022 Sep 7.
Suspected or confirmed antibiotic allergy is a frequent clinical circumstance that influences antimicrobial prescription and often leads to the avoidable use of less efficacious and/or more toxic or costly drugs than first-line antimicrobials. Optimizing antimicrobial therapy in patients with antibiotic allergy labels has become one of the priorities of antimicrobial stewardship programs in several countries. These guidelines aim to make recommendations for the systematic approach to patients with suspected or confirmed antibiotic allergy based on current evidence. An expert panel (11 members of various scientific societies) formulated questions about the management of patients with suspected or confirmed antibiotic allergy. A systematic literature review was performed by a medical librarian. The questions were distributed among panel members who selected the most relevant references, summarized the evidence, and formulated graded recommendations when possible. The answers to all the questions were finally reviewed by all panel members. A systematic approach to patients with suspected or confirmed antibiotic allergy was recommended to improve antibiotic selection and, consequently, clinical outcomes. A clinically oriented, 3-category risk-stratification strategy was recommended for patients with suspected antibiotic allergy. Complementary assessments should consider both clinical risk category and preferred antibiotic agent. Empirical therapy recommendations for the most relevant clinical syndromes in patients with suspected or confirmed ß-lactam allergy were formulated, as were recommendations on the implementation and monitoring of the impact of the guidelines. Antimicrobial stewardship programs and allergists should design and implement activities that facilitate the most appropriate use of antibiotics in these patients.
疑似或确诊的抗生素过敏是一种常见的临床情况,会影响抗菌药物的处方,并且常常导致避免使用疗效较差和/或毒性更大或更昂贵的药物,而不是一线抗菌药物。优化抗生素过敏标签患者的抗菌治疗已成为许多国家抗菌药物管理计划的重点之一。这些指南旨在根据现有证据为疑似或确诊抗生素过敏患者提供系统的处理建议。一个专家小组(来自多个科学学会的 11 名成员)提出了有关疑似或确诊抗生素过敏患者管理的问题。由一名医学图书馆员进行了系统的文献回顾。问题分发给小组成员,他们选择了最相关的参考文献,总结证据,并尽可能制定分级建议。最后由所有小组成员共同审查所有问题的答案。建议采用系统方法处理疑似或确诊抗生素过敏患者,以改善抗生素的选择,从而改善临床结局。建议对疑似抗生素过敏患者采用一种基于临床的、3 级风险分层策略。补充评估应同时考虑临床风险类别和首选抗生素药物。制定了疑似或确诊β-内酰胺类抗生素过敏患者最相关临床综合征的经验性治疗建议,并提出了实施和监测指南影响的建议。抗菌药物管理计划和过敏症专家应设计和实施活动,以促进这些患者最合理地使用抗生素。